Skip to main content
Premium Trial:

Request an Annual Quote

S. Wayne Kay, Thomas Umbel, and more

OncoGenesis has appointed S. Wayne Kay its president and COO effective Sept. 1. Also, Nico Arnold has joined the multiplex molecular cervical cancer screening firm as senior vice president, business and market development, and Brian Sunkel was appointed vice president, marketing and business development. 

Kay replaces Thomas Umbel, who will remain on OncoGenesis' board. Kay was most recently the founding president and CEO of Wireless Diagnostic Systems and s2a Molecular. Both are spinouts of the California Institute of Technology. 

Arnold has more than 30 years of experience in the diagnostics industry and was previously executive vice president, global commercial operations for Cepheid. Sunkel brings more than 25 years of experience in commercializing new technologies. He was director of international sales and marketing at Adeza Biomedical when it was acquired by Cytyc/Hologic. 

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.